Skip to content

Deep Brain Stimulation Lead Localization After Implantation

Research on Lead Localization for Deep Brain Stimulation After Implantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06196242
Enrollment
10
Registered
2024-01-09
Start date
2023-12-10
Completion date
2025-12-31
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Deep Brain Stimulation, Lead Localization, MRI

Brief summary

Deep brain stimulation (DBS) is an effective treatment for a variety of neurological and psychiatric disorders, with more than 200,000 patients implanted with DBS devices worldwide. Parkinson's disease is one of the typical indications.The clinical outcomes of DBS depends on the accurate implantation of the lead, and the identification of the lead locations is the basis for evaluating the effectiveness of the treatment. The aim of this study is to localize the implantation position of the lead based on postoperative MRI images and to reconstruct the relative spatial relationship between the lead and the stimulation target. By comparing with the lead position identified based on postoperative CT, this study will evaluate the accuracy of identifying the DBS lead position directly from MRI. This study may help to optimise the stimulation parameters and investigate the best stimulation targets for DBS patients.

Interventions

DIAGNOSTIC_TESTMRI and CT scan

An MRI scan of the head in about 30 minutes. During the scan, MRI thermometry will be performed to monitor for possible lead heating due to the interaction of the MRI radiofrequency field and the implanted devices. An CT plain scan of the head in about 10 minutes.

Sponsors

Tsinghua University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease patients with DBS devices, DBS implanted for at least 1 month. * Ability to tolerate DBS turn-off for at least 30 minutes. * DBS devices do not contain the ferromagnetic material. * The patients can fully understand the content of the trial and sign the informed consent form. * Able to comply to the requirements of this study.

Exclusion criteria

* Presence of other concomitant diseases that have or require implantation of pacemakers, defibrillators, cochlear implants, or other neurostimulation devices. * Patients who are abnormally sensitive to temperature or allergic to heat. * Patients with severe psychiatric disorders or cognitive impairment.

Design outcomes

Primary

MeasureTime frameDescription
Lead position1 dayThe accuracy of the lead localization will be evaluated by the distance between the identified position of the lead electrode and the center of the reconstructed stimulation target. The result of lead localization by CT will be used as the reference.

Countries

China

Contacts

Primary ContactFeng Zhang, Ph.D.
zhang-f@mail.tsinghua.edu.cn86-010-62794952

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026